- Home
- SNGX vs OTRK Comparison
SNGX vs OTRK Comparison
Compare SNGX & OTRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- OTRK
- Stock Information
- Founded
- SNGX 1987
- OTRK 2003
- Country
- SNGX United States
- OTRK United States
- Employees
- SNGX N/A
- OTRK N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- OTRK Misc Health and Biotechnology Services
- Sector
- SNGX Health Care
- OTRK Health Care
- Exchange
- SNGX Nasdaq
- OTRK Nasdaq
- Market Cap
- SNGX 6.5M
- OTRK 7.1M
- IPO Year
- SNGX 1987
- OTRK N/A
- Fundamental
- Price
- SNGX $2.16
- OTRK $1.47
- Analyst Decision
- SNGX
- OTRK Strong Buy
- Analyst Count
- SNGX 0
- OTRK 1
- Target Price
- SNGX N/A
- OTRK $45.00
- AVG Volume (30 Days)
- SNGX 199.2K
- OTRK 20.4K
- Earning Date
- SNGX 05-09-2025
- OTRK 04-14-2025
- Dividend Yield
- SNGX N/A
- OTRK N/A
- EPS Growth
- SNGX N/A
- OTRK N/A
- EPS
- SNGX N/A
- OTRK N/A
- Revenue
- SNGX $119,371.00
- OTRK $10,846,000.00
- Revenue This Year
- SNGX N/A
- OTRK $50.12
- Revenue Next Year
- SNGX N/A
- OTRK $55.26
- P/E Ratio
- SNGX N/A
- OTRK N/A
- Revenue Growth
- SNGX N/A
- OTRK N/A
- 52 Week Low
- SNGX $1.68
- OTRK $1.27
- 52 Week High
- SNGX $14.83
- OTRK $5.53
- Technical
- Relative Strength Index (RSI)
- SNGX 51.88
- OTRK 47.80
- Support Level
- SNGX $1.97
- OTRK $1.37
- Resistance Level
- SNGX $2.23
- OTRK $1.48
- Average True Range (ATR)
- SNGX 0.17
- OTRK 0.13
- MACD
- SNGX 0.02
- OTRK -0.00
- Stochastic Oscillator
- SNGX 86.36
- OTRK 26.74
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About OTRK Ontrak Inc.
Ontrak Inc is an artificial intelligence (AI)-powered and technology-enabled behavioral healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The Company's technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of our personalized care program. The company's integrated, technology-enabled OntrakTM solutions, a component of the PRE platform, are designed to treat members with behavioral conditions that cause chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.